Amplite® Colorimetric NAD/NADH Ratio Assay Kit
Price | |
Catalog Number | |
Unit Size | |
Quantity |
Telephone | 1-800-990-8053 |
Fax | 1-800-609-2943 |
sales@aatbio.com | |
International | See distributors |
Bulk request | Inquire |
Custom size | Inquire |
Shipping | Standard overnight for United States, inquire for international |
Certificate of Origin | Download PDF |
H-phrase | H303, H313, H333 |
Hazard symbol | XN |
Intended use | Research Use Only (RUO) |
R-phrase | R20, R21, R22 |
UNSPSC | 12352200 |
Overview | ![]() ![]() |
Platform
Absorbance microplate reader
Absorbance | 460 nm |
Recommended plate | Clear bottom |
Components
Example protocol
AT A GLANCE
- Prepare 25 µL of NADH standards and/or test samples
- Add 25 µL of NAD Extraction Solution
- Incubate at 37oC for 15 minutes
- Add 25 µL of Neutralization Solution
- Add 75 µL of NAD/NADH working solution
- Incubate at RT for 15 minutes to 2 hours
- Monitor Absorbance at 460 nm
It is highly recommended to incubate the cells with Lysis Buffer (Component G) at 37 °C and use the supernatant for the experiment.
Thaw one of each kit component at room temperature before starting the experiment.
CELL PREPARATION
For guidelines on cell sample preparation, please visit https://www.aatbio.com/resources/guides/cell-sample-preparation.html
PREPARATION OF STOCK SOLUTIONS
Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles
Add 200 µL of 1X PBS buffer into the vial of NADH standard (Component C) to make 1 mM (1 nmol/µL) NADH standard solution.
PREPARATION OF STANDARD SOLUTIONS
https://www.aatbio.com/tools/serial-dilution/15273
PREPARATION OF WORKING SOLUTION
Add 8 mL of NADH Probe Buffer (Component B-II) to the bottle of NAD/NADH Recycling Enzyme Mix (Component A), and mix well.
Add 2 mL NADH Probe (Component B-I) into the bottle of Component A+B-II and mix well to make NAD/NADH working solution.
Note This NAD/NADH working solution is enough for 125-200 assays. The working solution is not stable, use it promptly and avoid direct exposure to light.
Note One can try to use ddH2O such as 500 uL to dissolve the Component A, and then mix with B-II and B-I proportionally to make the NAD/NADH working solution for enough use only.
SAMPLE EXPERIMENTAL PROTOCOL
Table 1. Layout of NADH standards and test samples in a white/clear bottom 96-well microplate. NS= NADH Standards (NS1 - NS7, 100 to 1.56 µM), BL=Blank Control, TS=Test Samples.
BL | BL | TS | TS |
NS1 | NS1 | ... | ... |
NS2 | NS2 | ... | ... |
NS3 | NS3 | ||
NS4 | NS4 | ||
NS5 | NS5 | ||
NS6 | NS6 | ||
NS7 | NS7 |
Table 2. Reagent composition for each well. High concentration of NADH (e.g., >100 µM, final concentration) will cause saturated signal and make the calibration curve non-linear.
Well | Volume | Reagent |
NS1 - NS7 | 50 µL | Serial Dilutions (100 to 1.56 µM) |
BL | 50 µL | 1X PBS |
TS | 50 µL | Test Sample |
- Prepare NADH standards (NS), blank controls (BL), and test samples (TS) according to the layout provided in Tables 1 and 2.
Note Prepare cells or tissue samples as desired. Lysis Buffer (Component G) can be used for lysing the cells for convenience and incubate the cells with Lysis Buffer at 37oC for 15 minutes and use the supernatant for the experiment. - Add 50 µL of NAD/NADH working solution into each well of NADH standard, blank control, and test samples to make the total NAD/NADH assay volume of 100 µL/well.
- Incubate the reaction at room temperature for 15 minutes to 2 hours, protected from light.
- Monitor the absorbance increase with an absorbance plate reader at 460 nm.
Table 3. Layout of NADH standards and test samples in a white/clear 96-well microplate. NS= NADH Standards (NS1 - NS7, 100 to 1.56 µM); BL=Blank Control; TS=Test Samples; TS (NAD) = Test Samples treated with NAD Extraction Solution (Component D) for 10 to 15 minutes, then neutralized by Neutralization Solution (Component E).
BL | BL | TS | TS | TS (NAD) | TS (NAD) |
NS1 | NS1 | ... | ... | ||
NS2 | NS2 | ... | ... | ||
NS3 | NS3 | ||||
NS4 | NS4 | ||||
NS5 | NS5 | ||||
NS6 | NS6 | ||||
NS7 | NS7 |
Table 4. Reagent compositions for each well. High concentration of NADH (e.g., >100 µM, final concentration) will cause saturated signal and make the calibration curve non-linear.
NADH Standard | Blank Control | Test Sample (NAD+NADH) | Test Sample (NAD Extract) |
Serial Dilutions: 25 µL | 1X PBS: 25 µL | Test Sample: 25 µL | Test Sample: 25 µL |
Component F: 25 µL | Component F: 25 µL | Component F: 25 µL | Component D: 25 µL |
Incubate at 37 °C for 10 to 15 minutes | Incubate at 37 °C for 10 to 15 minutes | Incubate at 37 °C for 10 to 15 minutes | Incubate at 37 °C for 10 to 15 minutes |
Component F: 25 µL | Component F: 25 µL | Component F: 25 µL | Component E: 25 µL |
Total: 75 µL | Total: 75 µL | Total: 75 µL | Total: 75 µL |
Refer to Tables 3 & 4 for compositions of each well.
- For NAD Extraction (NAD amount): Add 25 µL of NAD Extraction Solution (Component D) into the wells of NAD/NADH containing test samples. Incubate at 37oC for 10 to 15 minutes, then add 25 µL of Neutralization Solution (Component E) to neutralize the NAD extracts as described in Tables 3 & 4.
- For Total NAD and NADH (Total amount): Add 25 µL of Extraction Control Solution (Component F) into the wells of NADH standards and NAD/NADH containing test samples. Incubate at room 37oC for 10 to 15 minutes, and then add 25 µL of Extraction Control Solution (Component F) as described in Tables 3 and 4.
Note Prepare cells or tissue samples as desired. Lysis Buffer (Component G) can be used for lysing the cells for convenience.
Add 75 µL of NAD/NADH working solution into each well of NADH standard, blank control, and test samples (NAD/NADH), and test sample (NAD Extract) to make the total assay volume of 150 µL/well.
Incubate the reaction at room temperature for 15 minutes to 2 hours (We tested 60 minutes in the figure shown), protected from light
Monitor the absorbance increase with an absorbance plate reader at 460 nm.
Images


Citations
Authors: Goldmann, Oliver and Medina, Eva
Journal: Cellular and Molecular Life Sciences (2023): 221
Authors: Rimal, Suman and Tantray, Ishaq and Li, Yu and Pal Khaket, Tejinder and Li, Yanping and Bhurtel, Sunil and Li, Wen and Zeng, Cici and Lu, Bingwei
Journal: EMBO reports (2023): e55548
Authors: Bertuccio, Maria Paola and Acri, Giuseppe and Ientile, Riccardo and Caccamo, Daniela and Curr{\`o}, Monica
Journal: Biomedicines (2023): 3129
Authors: Yan, Lu and Liu, Chu-han and Xu, Li and Qian, Yi-yun and Song, Ping-ping and Wei, Min and Liu, Bao-lin
Journal: CNS Neuroscience \& Therapeutics (2022)
Authors: Ye, Mingzhou and Zhao, Yi and Wang, Yuyuan and Xie, Ruosen and Tong, Yao and Sauer, John-Demian and Gong, Shaoqin
Journal: Nature Nanotechnology (2022): 1--11
Authors: Allie, Robert
Journal: (2022)
Authors: Luo, Gang and Xiao, Lin and Wang, Dongxia and Wang, Ning and Luo, Can and Yang, Xuefeng and Hao, Liping
Journal: The Journal of Nutritional Biochemistry (2021): 108568
Authors: Luo, Gang and Xiao, Lin and Wang, Dongxia and Wang, Ning and Luo, Can and Yang, Xuefeng and Hao, Liping
Journal: Toxicology in Vitro (2020): 104808
Authors: Nazari Soltan Ahmad, Saeed and Sanajou, Davoud and Kalantary-Charvadeh, Ashkan and Hosseini, Vahid and Roshangar, Leila and Khojastehfard, Mehran and Haiaty, Sanya and Mesgari-Abbasi, Mehran
Journal: Basic \& Clinical Pharmacology \& Toxicology (2020): 364--373
Authors: Mokarizadeh, Narmin and Karimi, Pouran and Erfani, Marjan and Sadigh-Eteghad, Saeed and Maroufi, Nazila Fathi and Rashtchizadeh, Nadereh
Journal: International Immunopharmacology (2020): 106300
Application notes
Acetylcholinesterase Inhibitory Activity of Pigment Echinochrome A
Ameliorative Effect of Novel Vitamin Formula with Herbal Extracts on Scopolamine-Induced Alzheimer's Disease
An Increase in Plasma Homovanillic Acid with Cocoa Extract Consumption Is Associated with the Alleviation of Depressive Symptoms in Overweight or Obese Adults
Attenuation of lysyl oxidase and collagen gene expression in keratoconus patient corneal epithelium corresponds to disease severity